TERRAN BIOSCIENCES
Terran Biosciences is developing therapeutics and technologies to change the lives of patients with neurological and psychiatric diseases.
TERRAN BIOSCIENCES
Social Links:
Industry:
Biotechnology Health Care Medical Neuroscience
Founded:
2017-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.terranbiosciences.com
Total Employee:
11+
Status:
Active
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Tag Manager Google Analytics LetsEncrypt Amazon SSL By Default Global Site Tag HSTS
Similar Organizations
Advanced Neural Dynamics
Advanced Neural Dynamics is a drug discovery company that provides neuroprotection against agents causing neurological impairment.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Gaitaid
Gaitaid is a medical device that assists patients with neurological impairments in improving their mobility.
PanTheryx
PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.
Starfish Neuroscience
Starfish Neuroscience is a company that creates brain interfaces for the treatment of neurological and neuropsychiatric illnesses.
Zigy.com
Zigy.com is India’s premier market place where users can buy medicines online & healthcare products online from a wide range of categories.
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-03-11 | Concert's CNS therapeutics | Concert's CNS therapeutics acquired by Terran Biosciences | N/A |
Investors List
Noetic Fund
Noetic Fund investment in Venture Round - Terran Biosciences
Victor Douce
Victor Douce investment in Venture Round - Terran Biosciences
PsyMed Ventures
PsyMed Ventures investment in Venture Round - Terran Biosciences
THE CATALYTIC IMPACT FOUNDATION (CIF)
THE CATALYTIC IMPACT FOUNDATION (CIF) investment in Venture Round - Terran Biosciences
AA Sons
AA Sons investment in Seed Round - Terran Biosciences
Tabula Rasa Ventures
Tabula Rasa Ventures investment in Seed Round - Terran Biosciences
Official Site Inspections
http://www.terranbiosciences.com
- Host name: a0b1d980e1f2226c6.awsglobalaccelerator.com
- IP address: 52.223.52.2
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Terran Biosciences"
Terran Biosciences
Phase 3 selective serotonin 2A receptor antagonists for the treatment of various neuropsychiatric illnesses. Tested in over 15,000 patients across more than 100 clinical trials, Terran is …See details»
Terran Company Profile 2024: Valuation, Funding
Terran General Information Description. Operator of a drug development platform intended to develop a portfolio of therapeutics and technologies. The company's tech-enabled platform provides novel psychedelic-based therapeutics for …See details»
TERRAN BIOSCIENCES INC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TERRAN BIOSCIENCES INC of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Terran Biosciences - Crunchbase Company Profile & Funding
Terran Biosciences is developing therapeutics and technologies to change the lives of patients with neurological and psychiatric diseases.See details»
Terran Biosciences - LinkedIn
Terran Biosciences Biotechnology Research Miami, FL 2,166 followers Transforming the lives of patients with neurological and psychiatric illnessesSee details»
Terran Biosciences - Drug pipelines, Patents, Clinical trials - Synapse
Explore Terran Biosciences with its drug pipeline, therapeutic area, technology platform, 15 news, Drug:Therapeutic program (CoNCERT Pharmaceuticals), TR-36.See details»
Terran Biosciences - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Terran Biosciences - Overview, News & Similar companies
Who is Terran Biosciences. Terran is a biotech platform company developing a portfolio of therapeutics and technologies for patients with neurological and psychiatric disease s. Backed …See details»
Terran Biosciences CEO to Deliver Keynote Speech at Microdose's …
Nov 2, 2023 New York, New York--(Newsfile Corp. - November 2, 2023) - Terran Biosciences, a biotech platform company dedicated to the development of transformational therapeutics for …See details»
Terran Biosciences Granted US Patent for the World’s First New …
MIAMI, April 17, 2024--Terran Biosciences granted a patent for new salts & polymorphs of MDMA; the world's only granted composition of matter patent on a new form of MDMA.See details»
Terran Biosciences - BIO International Convention 2024
Jun 5, 2024 Terran Biosciences is a biotech platform company devoted to the development of transformative therapeutics and technologies for patients with neurological and psychiatric …See details»
Terran Biosciences Receives Notice of Allowance for Four US …
Dec 8, 2023 Terran also received a notice of allowance for a patent covering the world’s first orally active prodrugs of DMT and 5-MeO-DMT. DMT is a psychedelic compound that is not …See details»
Terran Biosciences announces acquisition of a portfolio of novel …
Mar 11, 2022 About Terran Biosciences, Inc. Terran is a biotech platform company developing a portfolio of therapeutics and technologies for patients with neurological and psychiatric diseases.See details»
Terran Biosciences announces licensing deal with Columbia …
NEW YORK, March 16, 2022 /PRNewswire/ -- Terran Biosciences, Inc. ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics and …See details»
Terran Biosciences Receives Notice of Allowance for Four US …
Dec 8, 2023 MIAMI--(BUSINESS WIRE)--Terran Biosciences, Inc.. ("Terran"), a biotech platform company developing therapeutics and technologies for patients with neuropsychiatric …See details»
TerXT by Terran Biosciences
Next generation long-acting prodrugs of Xanomeline and TrospiumSee details»
Terran Biosciences Receives FDA Clearance for NM-101, the …
MIAMI, December 20, 2023--Terran Biosciences, Inc. ("Terran"), a biotech platform company developing therapeutics and technologies for patients with neuropsychiatric illnesses, has …See details»
Terran Biosciences announces licensing deal with Sanofi for two …
Apr 21, 2022 Terran to advance the development of two of Sanofi's Phase 3 CNS therapeutics; Transaction includes worldwide exclusive rights for development and commercialization in all …See details»
Terran Biosciences Announces Development of TerXT, a …
May 20, 2024 MIAMI--(BUSINESS WIRE)--Terran Biosciences Inc.. ("Terran"), a biotech platform company developing therapeutics and technologies for patients with neuropsychiatric …See details»
Terran Biosciences announces exclusive licensing deal with
Jun 2, 2023 Terran Biosciences, Inc. has entered into an agreement with French pharmaceutical company Pierre Fabre Médicament S.A.S for worldwide exclusive rights to develop and …See details»